Literature DB >> 34954734

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

Nicola Cotugno1,2, Chiara Pighi1, Elena Morrocchi1, Alessandra Ruggiero1, Donato Amodio1, Chiara Medri1, Luna Colagrossi3, Cristina Russo3, Silvia Di Cesare1, Veronica Santilli1, Emma Concetta Manno1, Paola Zangari1, Carmela Giancotta1, Stefania Bernardi1, Luciana Nicolosi1, Marta Ciofi Degli Atti4, Massimiliano Raponi4, Salvatore Zaffina5, Sara Alfieri6, Richard Kirk6, Carlo Federico Perno3, Paolo Rossi1,2, Antonio Amodeo6, Paolo Palma1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34954734     DOI： 10.1097/TP.0000000000003999

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.

Authors:  Elena Morrocchi; Chiara Pighi; Giuseppe Rubens Pascucci; Nicola Cotugno; Chiara Medri; Donato Amodio; Luna Colagrossi; Alessandra Ruggiero; Emma Concetta Manno; Chiara Casamento Tumeo; Stefania Bernardi; Kinga K Smolen; Carlo Federico Perno; Al Ozonoff; Paolo Rossi; Ofer Levy; Paolo Palma
Journal:  Clin Infect Dis       Date:  2022-08-15       Impact factor: 20.999

Review 2.  Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.

Authors:  Paul Moss; Francis Berenbaum; Giuseppe Curigliano; Ayelet Grupper; Thomas Berg; Shanti Pather
Journal:  Vaccine       Date:  2022-05-27       Impact factor: 4.169

3.  Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.

Authors:  Michaela Bitzenhofer; Franziska Suter-Riniker; Matthias B Moor; Daniel Sidler; Michael P Horn; Anna Gschwend; Cornelia Staehelin; Andri Rauch; Arthur Helbling; Lukas Jörg
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

4.  Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome.

Authors:  Diletta Valentini; Nicola Cotugno; Vittorio Scoppola; Chiara Di Camillo; Luna Colagrossi; Emma Concetta Manno; Carlo Federico Perno; Cristina Russo; Paolo Palma; Paolo Rossi; Alberto Villani
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

5.  Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study.

Authors:  Maria Elena Romero-Ibarguengoitia; Arnulfo González-Cantú; Diego Rivera-Salinas; Yodira Guadalupe Hernández-Ruíz; Ana Gabriela Armendariz-Vázquez; Irene Antonieta Barco-Flores; Rosalinda González-Facio; Miguel Ángel Sanz-Sánchez
Journal:  Vaccines (Basel)       Date:  2022-07-17

6.  Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.

Authors:  Nicola Cotugno; Enrica Franzese; Giulia Angelino; Donato Amodio; Erminia Francesca Romeo; Francesca Rea; Simona Faraci; Renato Tambucci; Elisa Profeti; Emma Concetta Manno; Veronica Santilli; Gioacchino Andrea Rotulo; Chiara Pighi; Chiara Medri; Elena Morrocchi; Luna Colagrossi; Giuseppe Rubens Pascucci; Diletta Valentini; Alberto Villani; Paolo Rossi; Paola De Angelis; Paolo Palma
Journal:  Vaccines (Basel)       Date:  2022-07-11

7.  Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.

Authors:  Hari Shankar Meshram; Vivek Kute; Hemant Rane; Ruchir Dave; Subho Banerjee; Vineet Mishra; Sanshriti Chauhan
Journal:  Transpl Infect Dis       Date:  2022-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.